Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Zeria Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| Zeria Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| Zeria Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| Zeria Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 1 |
| Zeria Pharmaceutical Co., Ltd., Medical Devices Deals, 2010 to YTD 2016 | 9 | 1 |
| Zeria Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 10 | 2 |
| Zeria Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deal Details | 12 | 20 |
| Asset Purchase | 12 | 1 |
| Tillotts Pharma Acquires Entocort from AstraZeneca | 12 | 1 |
| Venture Financing | 13 | 1 |
| Cancer Prevention Pharma Raises US$0.4 Million In Venture Financing | 13 | 1 |
| Cancer Prevention Pharma Raises Funds Through Venture Financing | 14 | 1 |
| Cancer Prevention Pharma Secures US$0.55 Million In Venture Financing | 15 | 1 |
| Partnerships | 16 | 1 |
| Solid Form Solutions Enters Into Co-Promotion Agreement With Tillotts Pharma | 16 | 1 |
| Cambrex Enters Into Co-Development Agreement With Tillotts Pharma | 17 | 1 |
| Cancer Prevention Pharma Partners with SWOG | 18 | 1 |
| Licensing Agreements | 19 | 1 |
| Sucampo Pharma Enters into Option Agreement with Cancer Prevention Pharma | 19 | 1 |
| Tillotts Pharma Enters into Licensing Agreement with Numab | 20 | 1 |
| Eisai Enters into Licensing Agreement with Zeria Pharma for Proton Pump Inhibitor | 21 | 1 |
| Tillotts Pharma Amends Licensing Agreement with Cancer Prevention Pharma | 22 | 2 |
| Vifor Pharma Enters Into Licensing Agreement With Zeria Pharma For Ferinject | 24 | 2 |
| Tillotts Pharma Enters Into Licensing Agreement With The School of Pharmacy | 26 | 1 |
| Equity Offering | 27 | 1 |
| Cancer Prevention Pharma to Raise up to USD27 Million in IPO | 27 | 2 |
| Debt Offering | 29 | 1 |
| Cancer Prevention Pharma Raises USD2.3 Million in Private Placement of Notes Due 2018 | 29 | 1 |
| Acquisition | 30 | 1 |
| Zeria Pharma Acquires Remaining 15% Stake In ZPD From Rorvig | 30 | 1 |
| Zeria Pharma Acquires Biofac | 31 | 1 |
| Zeria Pharmaceutical Co., Ltd. - Key Competitors | 32 | 1 |
| Key Employees | 33 | 1 |
| Locations And Subsidiaries | 34 | 2 |
| Head Office | 34 | 1 |
| Other Locations &Subsidiaries | 34 | 2 |
| Appendix | 36 | 1 |
| Methodology | 36 | 1 |
| About GlobalData | 36 | 1 |
| Contact Us | 36 | 1 |
| Disclaimer | 36 | 1 |